Cargando…
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between the development of chemoresistance, EMT, and the contribution of platelets to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664081/ https://www.ncbi.nlm.nih.gov/pubmed/29064388 http://dx.doi.org/10.3390/cancers9100142 |
_version_ | 1783274934055731200 |
---|---|
author | Elaskalani, Omar Falasca, Marco Moran, Niamh Berndt, Michael C. Metharom, Pat |
author_facet | Elaskalani, Omar Falasca, Marco Moran, Niamh Berndt, Michael C. Metharom, Pat |
author_sort | Elaskalani, Omar |
collection | PubMed |
description | Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between the development of chemoresistance, EMT, and the contribution of platelets to the process, is still unclear. Here we report that platelets regulate the expression of (1) human equilibrative nucleoside transporter 1 (hENT1) and (2) cytidine deaminase (CDD), markers of gemcitabine resistance in pancreatic cancer. Human ENT1 (hENT1) is known to enable cellular uptake of gemcitabine while CDD deactivates gemcitabine. Knockdown experiments demonstrate that Slug, a mesenchymal transcriptional factor known to be upregulated during EMT, regulates the expression of hENT1 and CDD. Furthermore, we demonstrate that platelet-derived ADP and ATP regulate Slug and CDD expression in pancreatic cancer cells. Finally, we demonstrate that pancreatic cancer cells express the purinergic receptor P2Y(12), an ADP receptor found mainly on platelets. Thus ticagrelor, a P2Y(12) inhibitor, was used to examine the potential therapeutic effect of an ADP receptor antagonist on cancer cells. Our data indicate that ticagrelor negated the survival signals initiated in cancer cells by platelet-derived ADP and ATP. In conclusion, our results demonstrate a novel role of platelets in modulating chemoresistance in pancreatic cancer. Moreover, we propose ADP/ATP receptors as additional potential drug targets for treatment of pancreatic cancer. |
format | Online Article Text |
id | pubmed-5664081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56640812017-11-06 The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance Elaskalani, Omar Falasca, Marco Moran, Niamh Berndt, Michael C. Metharom, Pat Cancers (Basel) Article Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between the development of chemoresistance, EMT, and the contribution of platelets to the process, is still unclear. Here we report that platelets regulate the expression of (1) human equilibrative nucleoside transporter 1 (hENT1) and (2) cytidine deaminase (CDD), markers of gemcitabine resistance in pancreatic cancer. Human ENT1 (hENT1) is known to enable cellular uptake of gemcitabine while CDD deactivates gemcitabine. Knockdown experiments demonstrate that Slug, a mesenchymal transcriptional factor known to be upregulated during EMT, regulates the expression of hENT1 and CDD. Furthermore, we demonstrate that platelet-derived ADP and ATP regulate Slug and CDD expression in pancreatic cancer cells. Finally, we demonstrate that pancreatic cancer cells express the purinergic receptor P2Y(12), an ADP receptor found mainly on platelets. Thus ticagrelor, a P2Y(12) inhibitor, was used to examine the potential therapeutic effect of an ADP receptor antagonist on cancer cells. Our data indicate that ticagrelor negated the survival signals initiated in cancer cells by platelet-derived ADP and ATP. In conclusion, our results demonstrate a novel role of platelets in modulating chemoresistance in pancreatic cancer. Moreover, we propose ADP/ATP receptors as additional potential drug targets for treatment of pancreatic cancer. MDPI 2017-10-24 /pmc/articles/PMC5664081/ /pubmed/29064388 http://dx.doi.org/10.3390/cancers9100142 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Elaskalani, Omar Falasca, Marco Moran, Niamh Berndt, Michael C. Metharom, Pat The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title_full | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title_fullStr | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title_full_unstemmed | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title_short | The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance |
title_sort | role of platelet-derived adp and atp in promoting pancreatic cancer cell survival and gemcitabine resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664081/ https://www.ncbi.nlm.nih.gov/pubmed/29064388 http://dx.doi.org/10.3390/cancers9100142 |
work_keys_str_mv | AT elaskalaniomar theroleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT falascamarco theroleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT moranniamh theroleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT berndtmichaelc theroleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT metharompat theroleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT elaskalaniomar roleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT falascamarco roleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT moranniamh roleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT berndtmichaelc roleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance AT metharompat roleofplateletderivedadpandatpinpromotingpancreaticcancercellsurvivalandgemcitabineresistance |